In The News

2504, 2017

EurekAlert highlights AIM2CERV study with clinical trial site at the Medical College of Georgia at Augusta University

Melanie Higham 2017-04-26T14:41:35+00:00 April 25th, 2017|

1804, 2017

Loncar features CEO Dan O’Connor in “Get to Know the Company: Advaxis” video

Melanie Higham 2017-04-21T14:35:12+00:00 April 18th, 2017|

1703, 2017

Cervical Cancer News covers unprecedented survival rates in metastatic cervical cancer study

Melanie Higham 2017-04-21T14:58:08+00:00 March 17th, 2017|

603, 2017

Advaxis featured in FierceBiotech on IND acceptance for Amgen-partnered neoantigen cancer vaccine

Melanie Higham 2017-04-21T15:00:00+00:00 March 6th, 2017|

2702, 2017

Xconomy highlights Advaxis’ deal with SELLAS to develop new cancer immunotherapy

Melanie Higham 2017-04-21T15:02:47+00:00 February 27th, 2017|

702, 2017

First patient dosed in Advaxis’ Phase 3 AIM2CERV trial featured in BioWorld

Melanie Higham 2017-04-21T15:04:07+00:00 February 7th, 2017|

202, 2017

PharmaVOICE discusses the future of immunotherapies with industry leaders, including Advaxis CSO Robert Petit

Melanie Higham 2017-04-21T15:42:08+00:00 February 2nd, 2017|

2301, 2017

CFO Sara Bonstein featured in CFO Thought Leader podcast, “Building a Biotech Wonder”

Melanie Higham 2017-04-21T15:44:20+00:00 January 23rd, 2017|

1201, 2017

CEO Dan O’Connor discusses leadership with Investor’s Business Daily in ‘Officers eat last in the mess hall’

Melanie Higham 2017-04-21T15:47:34+00:00 January 12th, 2017|

1312, 2016

CSO Robert Petit discusses algorithms for cancer vaccines and the TESLA Consortium with Nature

Melanie Higham 2017-04-21T15:50:27+00:00 December 13th, 2016|

712, 2016

Investor Business Daily highlights the tools for innovation according to industry leaders, featuring CEO Dan O’Connor

Melanie Higham 2017-04-21T15:54:51+00:00 December 7th, 2016|

2611, 2016

Advaxis’ immunotherapies featured in Washington Post article about canine cancer research and crossover with human treatments

Melanie Higham 2017-04-21T15:56:48+00:00 November 26th, 2016|

2909, 2016

Nature highlights Advaxis’ neoantigen technology in personalized cancer article

Melanie Higham 2017-04-21T16:04:46+00:00 September 29th, 2016|

909, 2016

Advaxis’ manufacturing facility ribbon-cutting, attended by Gov. Chris Christie and BioNJ’s Debbie Hart, featured in NJBIZ

Melanie Higham 2017-04-21T15:59:19+00:00 September 9th, 2016|

2208, 2016

STAT News featured Advaxis’ turnaround story and listeria technology

Melanie Higham 2017-04-21T16:01:32+00:00 August 22nd, 2016|

1508, 2016

BioCentury highlights Advaxis’ global immunotherapy collaboration with Amgen to develop ADXS-NEO

Melanie Higham 2017-04-21T16:08:48+00:00 August 15th, 2016|

1108, 2016

Advaxis featured in Scrip story on personalized cancer vaccines, highlighting manufacturing time and cost

Melanie Higham 2017-04-21T16:10:38+00:00 August 11th, 2016|

308, 2016

BioWorld article features terms of the Advaxis, Amgen preclinical-stage immunotherapy alliance

Melanie Higham 2017-04-21T16:12:10+00:00 August 3rd, 2016|

1409, 2015

Advaxis Recognized by Farrah Fawcett Foundation in Huffington Post

jim 2016-01-07T16:59:17+00:00 September 14th, 2015|

1301, 2014

Advaxis featured in NJBIZ

jim 2016-01-07T17:30:13+00:00 January 13th, 2014|

2111, 2013

Advaxis Cancer Immunotherapy Featured on ABC News

jim 2016-01-07T17:30:41+00:00 November 21st, 2013|

2111, 2013

Advaxis canine trial featured on Arise News

jim 2016-03-03T22:10:51+00:00 November 21st, 2013|